B-Multi-tissue_structure	0	12	Antivascular	Antivascular	JJ	B-NP
O	13	20	actions	action	NNS	I-NP
O	21	23	of	of	IN	B-PP
B-Cellular_component	24	35	microtubule	microtubule	NN	B-NP
O	35	36	-	-	HYPH	O
O	36	43	binding	bind	VBG	B-NP
O	44	49	drugs	drug	NNS	I-NP
O	49	50	.	.	.	O

B-Cellular_component	51	62	Microtubule	Microtubule	NN	B-NP
O	62	63	-	-	HYPH	O
O	63	70	binding	bind	VBG	B-VP
O	71	76	drugs	drug	NNS	B-NP
O	77	78	(	(	(	O
O	78	81	MBD	MBD	NN	B-NP
O	81	82	)	)	)	O
O	83	86	are	be	VBP	B-VP
O	87	93	widely	widely	RB	I-VP
O	94	98	used	use	VBN	I-VP
O	99	101	in	in	IN	B-PP
B-Cancer	102	108	cancer	cancer	NN	B-NP
O	109	121	chemotherapy	chemotherapy	NN	I-NP
O	122	125	and	and	CC	O
O	126	130	also	also	RB	B-ADVP
O	131	135	have	have	VBP	B-VP
O	136	146	clinically	clinically	RB	B-NP
O	147	155	relevant	relevant	JJ	I-NP
O	156	170	antiangiogenic	antiangiogenic	JJ	I-NP
O	171	174	and	and	CC	I-NP
B-Multi-tissue_structure	175	183	vascular	vascular	JJ	I-NP
O	183	184	-	-	HYPH	I-NP
O	184	194	disrupting	disrupt	VBG	B-VP
O	195	205	properties	property	NNS	B-NP
O	205	206	.	.	.	O

O	207	212	These	These	DT	B-NP
B-Multi-tissue_structure	213	225	antivascular	antivascular	JJ	I-NP
O	226	233	actions	action	NNS	I-NP
O	234	237	are	be	VBP	B-VP
O	238	241	due	due	JJ	B-ADJP
O	242	244	in	in	IN	B-PP
O	245	249	part	part	NN	B-NP
O	250	252	to	to	TO	B-PP
O	253	259	direct	direct	JJ	B-NP
O	260	267	effects	effect	NNS	I-NP
O	268	270	on	on	IN	B-PP
B-Cell	271	282	endothelial	endothelial	JJ	B-NP
I-Cell	283	288	cells	cell	NNS	I-NP
O	288	289	,	,	,	O
O	290	293	and	and	CC	O
O	294	297	all	all	DT	B-NP
O	298	302	MBDs	MBD	NNS	I-NP
O	303	304	(	(	(	O
O	304	308	both	both	CC	O
B-Cellular_component	309	320	microtubule	microtubule	NN	B-NP
O	320	321	-	-	HYPH	B-VP
O	321	332	stabilizing	stabilize	VBG	B-NP
O	333	336	and	and	CC	I-NP
B-Cellular_component	337	348	microtubule	microtubule	NN	I-NP
O	348	349	-	-	HYPH	B-VP
O	349	362	destabilizing	destabilize	VBG	I-VP
O	362	363	)	)	)	O
O	364	371	inhibit	inhibit	VBP	B-VP
B-Cell	372	383	endothelial	endothelial	JJ	B-NP
I-Cell	384	388	cell	cell	NN	I-NP
O	389	402	proliferation	proliferation	NN	I-NP
O	402	403	,	,	,	O
O	404	413	migration	migration	NN	B-NP
O	413	414	,	,	,	O
O	415	418	and	and	CC	O
B-Tissue	419	423	tube	tube	NN	B-NP
O	424	433	formation	formation	NN	I-NP
O	434	436	in	in	FW	B-ADVP
O	437	442	vitro	vitro	FW	I-ADVP
O	442	443	,	,	,	O
O	444	451	actions	action	NNS	B-NP
O	452	456	that	that	WDT	B-NP
O	457	460	are	be	VBP	B-VP
O	461	468	thought	think	VBN	I-VP
O	469	471	to	to	TO	I-VP
O	472	482	correspond	correspond	VB	I-VP
O	483	485	to	to	TO	B-PP
O	486	497	therapeutic	therapeutic	JJ	B-NP
O	498	512	antiangiogenic	antiangiogenic	JJ	I-NP
O	513	520	actions	action	NNS	I-NP
O	520	521	.	.	.	O

O	522	524	In	In	IN	B-PP
O	525	533	addition	addition	NN	B-NP
O	533	534	,	,	,	O
O	535	538	the	the	DT	B-NP
B-Cellular_component	539	550	microtubule	microtubule	NN	I-NP
O	550	551	-	-	HYPH	B-VP
O	551	564	destabilizing	destabilize	VBG	B-NP
O	565	571	agents	agent	NNS	I-NP
O	572	577	cause	cause	VBP	B-VP
O	578	587	prominent	prominent	JJ	B-NP
O	588	595	changes	change	NNS	I-NP
O	596	598	in	in	IN	B-PP
B-Cell	599	610	endothelial	endothelial	JJ	B-NP
I-Cell	611	615	cell	cell	NN	I-NP
O	616	626	morphology	morphology	NN	I-NP
O	626	627	,	,	,	O
O	628	630	an	an	DT	B-NP
O	631	637	action	action	NN	I-NP
O	638	648	associated	associate	VBN	B-VP
O	649	653	with	with	IN	B-PP
O	654	659	rapid	rapid	JJ	B-NP
B-Multi-tissue_structure	660	668	vascular	vascular	JJ	I-NP
O	669	677	collapse	collapse	NN	I-NP
O	678	680	in	in	FW	B-ADVP
O	681	685	vivo	vivo	FW	I-ADVP
O	685	686	.	.	.	O

O	687	690	The	The	DT	B-NP
O	691	698	effects	effect	NNS	I-NP
O	699	701	on	on	IN	B-PP
B-Cell	702	713	endothelial	endothelial	JJ	B-NP
I-Cell	714	719	cells	cell	NNS	I-NP
O	720	725	occur	occur	VBP	B-VP
O	726	728	in	in	FW	B-ADVP
O	729	734	vitro	vitro	FW	I-ADVP
O	735	737	at	at	IN	B-PP
O	738	741	low	low	JJ	B-NP
O	742	746	drug	drug	NN	I-NP
O	747	761	concentrations	concentration	NNS	I-NP
O	761	762	,	,	,	O
O	763	768	which	which	WDT	B-NP
O	769	771	do	do	VBP	B-VP
O	772	775	not	not	RB	I-VP
O	776	782	affect	affect	VB	I-VP
B-Cellular_component	783	794	microtubule	microtubule	NN	B-NP
O	795	800	gross	gross	JJ	I-NP
O	801	811	morphology	morphology	NN	I-NP
O	811	812	,	,	,	O
O	813	815	do	do	VBP	B-VP
O	816	819	not	not	RB	I-VP
O	820	825	cause	cause	VB	I-VP
B-Cellular_component	826	837	microtubule	microtubule	NN	B-NP
O	838	846	bundling	bundling	NN	I-NP
O	847	849	or	or	CC	O
B-Cellular_component	850	861	microtubule	microtubule	NN	B-NP
O	862	866	loss	loss	NN	I-NP
O	867	870	and	and	CC	O
O	871	873	do	do	VBP	B-VP
O	874	877	not	not	RB	I-VP
O	878	884	induce	induce	VB	I-VP
B-Cell	885	889	cell	cell	NN	B-NP
O	890	895	cycle	cycle	NN	I-NP
O	896	902	arrest	arrest	NN	I-NP
O	902	903	,	,	,	O
O	904	913	apoptosis	apoptosis	NN	B-NP
O	913	914	,	,	,	O
O	915	917	or	or	CC	O
B-Cell	918	922	cell	cell	NN	B-NP
O	923	928	death	death	NN	I-NP
O	928	929	.	.	.	O

O	930	936	Rather	Rather	RB	B-ADVP
O	936	937	,	,	,	O
O	938	940	it	it	PRP	B-NP
O	941	944	has	have	VBZ	B-VP
O	945	949	been	be	VBN	I-VP
O	950	962	hypothesized	hypothesize	VBN	I-VP
O	963	967	that	that	IN	B-SBAR
O	967	968	,	,	,	O
O	969	971	at	at	IN	B-PP
O	972	975	low	low	JJ	B-NP
O	976	990	concentrations	concentration	NNS	I-NP
O	990	991	,	,	,	O
O	992	996	MBDs	MBD	NNS	B-NP
O	997	1004	produce	produce	VBP	B-VP
O	1005	1009	more	more	JJR	B-NP
O	1010	1016	subtle	subtle	JJ	I-NP
O	1017	1024	effects	effect	NNS	I-NP
O	1025	1027	on	on	IN	B-PP
B-Cellular_component	1028	1039	microtubule	microtubule	NN	B-NP
O	1040	1048	dynamics	dynamic	NNS	I-NP
O	1048	1049	,	,	,	O
O	1050	1055	block	block	VBP	B-VP
O	1056	1064	critical	critical	JJ	B-NP
B-Cell	1065	1069	cell	cell	NN	I-NP
O	1070	1079	signaling	signaling	NN	I-NP
O	1080	1088	pathways	pathway	NNS	I-NP
O	1088	1089	,	,	,	O
O	1090	1093	and	and	CC	O
O	1094	1101	prevent	prevent	VBP	B-VP
O	1102	1105	the	the	DT	B-NP
B-Cellular_component	1106	1118	microtubules	microtubule	NNS	I-NP
O	1119	1123	from	from	IN	B-PP
O	1124	1132	properly	properly	RB	B-ADVP
O	1133	1144	interacting	interact	VBG	B-VP
O	1145	1149	with	with	IN	B-PP
O	1150	1159	transient	transient	JJ	B-NP
B-Cellular_component	1160	1171	subcellular	subcellular	JJ	I-NP
I-Cellular_component	1172	1182	assemblies	assembly	NNS	I-NP
O	1183	1184	(	(	(	O
B-Cellular_component	1184	1189	focal	focal	JJ	B-NP
I-Cellular_component	1190	1199	adhesions	adhesion	NNS	I-NP
O	1200	1203	and	and	CC	I-NP
B-Cellular_component	1204	1212	adherens	adheren	NNS	I-NP
I-Cellular_component	1213	1222	junctions	junction	NNS	I-NP
O	1222	1223	)	)	)	O
O	1224	1229	whose	whose	WP$	B-NP
O	1230	1240	subsequent	subsequent	JJ	I-NP
O	1241	1254	stabilization	stabilization	NN	I-NP
O	1255	1258	and	and	CC	O
O	1258	1259	/	/	SYM	B-NP
O	1259	1261	or	or	CC	O
O	1262	1272	maturation	maturation	NN	B-NP
O	1273	1276	are	be	VBP	B-VP
O	1277	1285	required	require	VBN	I-VP
O	1286	1289	for	for	IN	B-PP
B-Cell	1290	1294	cell	cell	NN	B-NP
O	1295	1303	motility	motility	NN	I-NP
O	1304	1307	and	and	CC	O
B-Cell	1308	1312	cell	cell	NN	B-NP
O	1312	1313	-	-	HYPH	B-NP
B-Cell	1313	1317	cell	cell	NN	I-NP
O	1318	1330	interactions	interaction	NNS	I-NP
O	1330	1331	.	.	.	O

O	1332	1336	This	This	DT	B-NP
O	1337	1343	review	review	NN	I-NP
O	1344	1348	will	will	MD	B-VP
O	1349	1354	focus	focus	VB	I-VP
O	1355	1357	on	on	IN	B-PP
O	1358	1364	recent	recent	JJ	B-NP
O	1365	1372	studies	study	NNS	I-NP
O	1373	1375	to	to	TO	B-VP
O	1376	1382	define	define	VB	I-VP
O	1383	1386	the	the	DT	B-NP
O	1387	1396	molecular	molecular	JJ	I-NP
O	1397	1407	mechanisms	mechanism	NNS	I-NP
O	1408	1411	for	for	IN	B-PP
O	1412	1415	the	the	DT	B-NP
B-Multi-tissue_structure	1416	1428	antivascular	antivascular	JJ	I-NP
O	1429	1436	actions	action	NNS	I-NP
O	1437	1439	of	of	IN	B-PP
O	1440	1443	the	the	DT	B-NP
O	1444	1448	MBDs	MBD	NNS	I-NP
O	1448	1449	,	,	,	O
O	1450	1461	information	information	NN	B-NP
O	1462	1466	that	that	WDT	B-NP
O	1467	1472	could	could	MD	B-VP
O	1473	1475	be	be	VB	I-VP
O	1476	1482	useful	useful	JJ	B-ADJP
O	1483	1485	in	in	IN	B-PP
O	1486	1489	the	the	DT	B-NP
O	1490	1504	identification	identification	NN	I-NP
O	1505	1507	or	or	CC	I-NP
O	1508	1514	design	design	NN	I-NP
O	1515	1517	of	of	IN	B-PP
O	1518	1524	agents	agent	NNS	B-NP
O	1525	1530	whose	whose	WP$	B-NP
O	1531	1538	actions	action	NNS	I-NP
O	1539	1543	more	more	RBR	B-VP
O	1544	1555	selectively	selectively	RB	I-VP
O	1556	1562	target	target	VB	I-VP
O	1563	1566	the	the	DT	B-NP
B-Multi-tissue_structure	1567	1572	tumor	tumor	NN	I-NP
I-Multi-tissue_structure	1573	1584	vasculature	vasculature	NN	I-NP
O	1584	1585	.	.	.	O

